lunes, 7 de septiembre de 2020

NIH Genetic Testing Registry (GTR) now accepting microbe tests including SARS-CoV-2 / COVID-19 tests NCBI, September 2020

Hot Topics of the Day|PHGKB

a person with a respirator holding a disc with optical mapping

The profound impact of the COVID-19 pandemic prompted the NIH Genetic Testing Registry (GTR) to expand its scope to include microbe tests. We will focus initially on molecular tests to detect the SARS-CoV-2 virus and serology tests to detect viral antigens and antibodies to the virus.

No hay comentarios:

Publicar un comentario